Evaluation of KRASG12C Inhibitor Responses in Novel Murine KRASG12C Lung Cancer Cell Line Models
D. J. Sisler, T. K. Hinz, A. T. Le, E. K. Kleczko, R. A. Nemenoff, L. E. Heasley
This paper develops three novel murine KRASG12C-driven lung cancer cell lines to evaluate responses to KRASG12C inhibitors and identify combination strategies for improved therapeutic outcomes.
bioRxiv · Aug 19, 2022Cancer Biology